Trifecta Outcomes After Robotic-assisted Laparoscopic Prostatectomy

Urology

Volumn 74, Issue 3, 2009, Pages 619-623

  Shikanov, Sergey A ^a   Zorn, Kevin C ^a   Zagaja, Gregory P ^a   Shalhav, Arieh L ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CONTINENCE; CONTROLLED STUDY; DATA BASE; FOLLOW UP; HUMAN; INTERVIEW; LAPAROSCOPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATECTOMY; RECURRENT DISEASE; ROBOTIC ASSISTED LAPAROSCOPIC PROSTATECTOMY; ROBOTICS;

ADULT; AGED; ERECTILE DYSFUNCTION; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATECTOMY; ROBOTICS; TREATMENT OUTCOME; URINARY INCONTINENCE;

EID: 69249210985     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.02.082     Document Type: Article

References (16)

1. http://www.merriam-webster.com/dictionary/trifecta
2. Benson M.C. Impact of laparoscopy on prostate cancer treatment (2004), Advanced Urologic Laparoscopy Meeting, Rome, Italy
3. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
4. Greene K.L., Cowan J.E., Cooperberg M.R., et al. Who is the average patient presenting with prostate cancer?. Urology 66 (2005) 76-82
5. Lee C.M., Lee R.J., Handrahan D.L., et al. Comparison of late rectal toxicity from conventional versus three-dimensional conformal radiotherapy for prostate cancer: analysis of clinical and dosimetric factors. Urology 65 (2005) 114-119
6. Murat F.J., and Gelet A. A current status of high-intensity focused ultrasound for prostate cancer: technology, clinical outcomes, and future. Curr Urol Rep 9 (2008) 113-121
7. Bianco F.J., Scardino P.T., and Eastham J.A. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta"). Urology 66 (2005) 83-94
8. Eastham J.A., Scardino P.T., and Kattan M.W. Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram. J Urol 179 (2008) 2207-2210
9. Pierorazio P.M., Spencer B.A., McCann T.R., et al. Preoperative risk stratification predicts likelihood of concurrent PSA-free survival, continence, and potency (the trifecta analysis) after radical retropubic prostatectomy. Urology 70 (2007) 717-722
10. Salomon L., Saint F., Anastasiadis A.G., et al. Combined reporting of cancer control and functional results of radical prostatectomy. Eur Urol 44 (2003) 656-660
11. Zorn K.C., Gofrit O.N., Orvieto M.A., et al. Robotic-assisted laparoscopic prostatectomy: functional and pathologic outcomes with interfascial nerve preservation. Eur Urol 51 (2007) 755-763
12. Litwin M.S., Hays R.D., Fink A., et al. The UCLA Prostate Cancer Index-development, reliability, and validity of a health-related quality of life measure. Med Care 36 (1998) 1002-1012
13. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol 17 (1999) 168-172
14. Litwin M.S., Lubeck D.P., Henning J.M., et al. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the CaPSURE database. J Urol 159 (1998) 1988-1992
15. Schroeck F.R., Krupski T.L., Sun L., et al. Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy. Eur Urol 54 (2008) 785-793
16. Hu J.C., Wang Q., Pashos C.L., et al. Utilization and outcomes of minimally invasive radical prostatectomy. J Clin Oncol 24 (2008) 2278-2284